Eusol Biotech Company Description

Eusol Biotech Co.,Ltd. focuses on research and development of new drugs for the treatment of nerve injuries.

The company’s pipeline includes ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) for spinal cord injury, and SM-1, a 3-in-1 combination sleeping aid.

It also offers small molecule drugs including EPS221, a selective serotonin reuptake inhibitor; EPS222, a calcium channel blocker for cardiovascular disease; EPS251, a drug for rheumatology/anti-inflammation; and EA2501, a drug for anticoagulation.

The company was founded in 1994 and is headquartered in Taipei, Taiwan.

Eusol Biotech Co.,Ltd.

Country	Taiwan
Founded	1994
Industry	Biotechnology
Sector	Healthcare
CEO	Wan-Ya Zhang

Contact Details

Address: No. 367, Fuxing N. Rd Taipei, 105401 Taiwan
Phone	886 2 2718 5128
Website	eusol-biotech.com

Stock Details

Ticker Symbol	6652
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006652001
SIC Code	2836

Key Executives

Name	Position
Wan-Ya Zhang	Manager
Bing Song Li	Accounting Supervisor